LHC Group, Inc. (NASDAQ:LHCG)’s share price reached a new 52-week high during mid-day trading on Wednesday . The company traded as high as $117.70 and last traded at $117.34, with a volume of 13988 shares. The stock had previously closed at $115.39.
LHCG has been the topic of a number of research analyst reports. Royal Bank of Canada boosted their price target on shares of LHC Group to $130.00 and gave the stock an “outperform” rating in a report on Monday. Robert W. Baird boosted their price objective on LHC Group from $98.00 to $120.00 and gave the company a “neutral” rating in a research note on Monday, March 4th. SunTrust Banks boosted their price objective on LHC Group to $130.00 and gave the company a “buy” rating in a research note on Friday, March 1st. Zacks Investment Research cut LHC Group from a “hold” rating to a “sell” rating in a research report on Thursday, May 2nd. Finally, Jefferies Financial Group upped their price target on LHC Group from $125.00 to $130.00 and gave the company a “buy” rating in a research report on Thursday, May 9th. Four analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus price target of $118.50.
The stock has a market cap of $3.69 billion, a price-to-earnings ratio of 33.31, a PEG ratio of 1.99 and a beta of 0.87. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.57 and a quick ratio of 1.57.
LHC Group (NASDAQ:LHCG) last announced its quarterly earnings results on Wednesday, May 8th. The health services provider reported $0.98 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.90 by $0.08. LHC Group had a return on equity of 8.43% and a net margin of 3.83%. The firm had revenue of $502.59 million for the quarter, compared to analysts’ expectations of $511.16 million. As a group, equities analysts expect that LHC Group, Inc. will post 4.3 EPS for the current fiscal year.
In related news, CEO Keith G. Myers sold 5,164 shares of the company’s stock in a transaction that occurred on Wednesday, April 3rd. The shares were sold at an average price of $108.75, for a total value of $561,585.00. Following the transaction, the chief executive officer now directly owns 96,315 shares in the company, valued at $10,474,256.25. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, COO Donald Dwayne Stelly sold 15,151 shares of the company’s stock in a transaction that occurred on Monday, March 11th. The stock was sold at an average price of $107.06, for a total transaction of $1,622,066.06. Following the completion of the transaction, the chief operating officer now owns 92,065 shares in the company, valued at $9,856,478.90. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 118,324 shares of company stock worth $12,816,300. Company insiders own 5.20% of the company’s stock.
Several hedge funds have recently bought and sold shares of LHCG. BlackRock Inc. boosted its stake in LHC Group by 2.6% in the first quarter. BlackRock Inc. now owns 4,686,353 shares of the health services provider’s stock worth $519,530,000 after buying an additional 120,016 shares in the last quarter. Wellington Management Group LLP boosted its stake in LHC Group by 0.9% in the first quarter. Wellington Management Group LLP now owns 1,484,162 shares of the health services provider’s stock worth $164,534,000 after buying an additional 12,644 shares in the last quarter. FMR LLC boosted its stake in LHC Group by 2.4% in the first quarter. FMR LLC now owns 1,151,105 shares of the health services provider’s stock worth $127,612,000 after buying an additional 27,272 shares in the last quarter. Norges Bank purchased a new stake in LHC Group in the fourth quarter worth approximately $51,535,000. Finally, Thrivent Financial for Lutherans boosted its stake in LHC Group by 9.1% in the fourth quarter. Thrivent Financial for Lutherans now owns 530,693 shares of the health services provider’s stock worth $49,822,000 after buying an additional 44,450 shares in the last quarter. Institutional investors own 94.07% of the company’s stock.
ILLEGAL ACTIVITY WARNING: This article was posted by Stock Observer and is owned by of Stock Observer. If you are viewing this article on another site, it was illegally copied and reposted in violation of US & international trademark & copyright law. The correct version of this article can be viewed at https://www.thestockobserver.com/2019/05/17/lhc-group-lhcg-sets-new-1-year-high-at-117-70.html.
LHC Group Company Profile (NASDAQ:LHCG)
LHC Group, Inc provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Home & Community-Based Services, Facility-Based Services and Healthcare Innovations.
Read More: What is Cost of Debt?
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.